AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Birch, E. E
Right arrow Articles by Hoffman, D. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Birch, E. E
Right arrow Articles by Hoffman, D. R
Agricola
Right arrow Articles by Birch, E. E
Right arrow Articles by Hoffman, D. R
American Journal of Clinical Nutrition, Vol. 81, No. 4, 871-879, April 2005
© 2005 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATION

Visual maturation of term infants fed long-chain polyunsaturated fatty acid–supplemented or control formula for 12 mo1,2,3

Eileen E Birch1, Yolanda S Castañeda1, Dianna H Wheaton1, David G Birch1, Ricardo D Uauy1 and Dennis R Hoffman1

1 From the Retina Foundation of the Southwest, Dallas, TX (EEB, YSC, DHW, DGB, and DRH), the Department of Ophthalmology (EEB and DGB), UT Southwestern Medical Center, Dallas, TX, and INTA, University of Chile, Santiago, Chile (RDU)

Background: Several studies found a benefit of long-chain polyunsaturated fatty acid (LCP) supplementation for visual or mental development, but others found no benefit. Likely contributors to differences among studies are the amount of LCP supplementation, functional outcomes, and sample size.

Objective: We evaluated LCP supplementation in amounts typical for human milk (based on local and worldwide surveys) in a large cohort of infants by using sweep visual evoked potential (VEP) acuity as the functional outcome.

Design: The study was a double-masked, randomized, controlled clinical trial in 103 term infants. By age 5 d, infants were randomly assigned to receive either formula with no docosahexaenoic acid (DHA) or arachidonic acid (ARA) or formula supplemented with DHA and ARA as 0.36% and 0.72%, respectively, of total fatty acids. Sweep VEP acuity was the primary outcome. Random dot stereoacuity, blood lipid profile, growth, and tolerance were secondary outcomes.

Results: VEP acuity in the LCP-supplemented group was significantly better than that in the control group at ages 6, 17, 26, and 52 wk. Stereoacuity in the LCP-supplemented group was significantly better than that in the control group at age 17 wk but not at ages 39 and 52 wk. By ages 17 and 39 wk, the red blood cell DHA concentration in the LCP-supplemented group was more than double and more than triple, respectively, that in the control group. Growth of infants fed LCP-supplemented and control formulas did not differ significantly, and both diets were well tolerated.

Conclusion: LCP supplementation of term infant formula during the first year of life yields clear differences in visual function and in total red blood cell lipid composition.

Key Words: Docosahexaenoic acid • infant • visual evoked potential • acuity • random dot stereoacuity




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. He, X. Qu, L. Cui, J. Wang, and J. X. Kang
Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid
PNAS, July 7, 2009; 106(27): 11370 - 11375.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. E Carlson
Early determinants of development: a lipid perspective
Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1523S - 1529S.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. C. DeMar Jr., C. DiMartino, A. W. Baca, W. Lefkowitz, and N. Salem Jr.
Effect of dietary docosahexaenoic acid on biosynthesis of docosahexaenoic acid from alpha-linolenic acid in young rats
J. Lipid Res., September 1, 2008; 49(9): 1963 - 1980.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M.-C. Huang, J. T. Brenna, A. C. Chao, C. Tschanz, D. A. Diersen-Schade, and H.-C. Hung
Differential Tissue Dose Responses of (n-3) and (n-6) PUFA in Neonatal Piglets Fed Docosahexaenoate and Arachidonoate
J. Nutr., September 1, 2007; 137(9): 2049 - 2055.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Singhal, R. Morley, T. J Cole, K. Kennedy, P. Sonksen, E. Isaacs, M. Fewtrell, A. Elias-Jones, T. Stephenson, and A. Lucas
Infant nutrition and stereoacuity at age 4-6 y
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 152 - 159.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. L Cheatham, J. Colombo, and S. E Carlson
n-3 Fatty acids and cognitive and visual acuity development: methodologic and conceptual considerations
Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1458 - 1466S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. M Arterburn, E. B. Hall, and H. Oken
Distribution, interconversion, and dose response of n-3 fatty acids in humans
Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1467 - 1476S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The American Society for Nutrition